{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:02:04Z","timestamp":1762459324655},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12016-015-8517-4","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T03:36:30Z","timestamp":1446089790000},"page":"88-98","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies"],"prefix":"10.1007","volume":"52","author":[{"given":"Ilaria","family":"Cavazzana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"8517_CR1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"M Dalakas","year":"1991","unstructured":"Dalakas M (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487\u20131498","journal-title":"N Engl J Med"},{"key":"8517_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"M Dalakas","year":"2003","unstructured":"Dalakas M, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"8517_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"8517_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"J Hoogendijk","year":"2004","unstructured":"Hoogendijk J, Amato A, Lecky B, Choy E, Lundberg I, Rose M et al (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337\u2013345","journal-title":"Neuromuscul Disord"},{"key":"8517_CR5","first-page":"447","volume":"55","author":"MC Hochberg","year":"1988","unstructured":"Hochberg MC (1988) Epidemiology of polymyositis\/dermatomyositis. Mt Sinai J Med 55:447\u2013452","journal-title":"Mt Sinai J Med"},{"key":"8517_CR6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","volume":"9","author":"IN Targoff","year":"1997","unstructured":"Targoff IN, Miller FW, Medsger TA Jr, Oddis CV (1997) Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheum 9:527\u2013535","journal-title":"Curr Opin Rheum"},{"key":"8517_CR7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/BOR.0b013e328313644c","volume":"20","author":"MJ Garlepp","year":"2008","unstructured":"Garlepp MJ, Mastaglia FL (2008) Inclusion body myositis: new insights into pathogenesis. Curr Opin Rheumatol 20:662\u2013668","journal-title":"Curr Opin Rheumatol"},{"key":"8517_CR8","first-page":"767","volume":"31","author":"H Linklater","year":"2013","unstructured":"Linklater H, Pipitone N, Rose MR et al (2013) Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol 31:767\u2013769","journal-title":"Clin Exp Rheumatol"},{"key":"8517_CR9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360\u2013374","journal-title":"Medicine (Baltimore)"},{"key":"8517_CR10","first-page":"668","volume":"22","author":"K Tanimoto","year":"1995","unstructured":"Tanimoto K, Nakano K, Kano S et al (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22:668\u2013674","journal-title":"J Rheumatol"},{"key":"8517_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL et al (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine 84:231\u2013249","journal-title":"Medicine"},{"key":"8517_CR12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MD.0000000000000222","volume":"93","author":"Y Troyanov","year":"2014","unstructured":"Troyanov Y, Targoff IN, Payette MP et al (2014) Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore) 93:318\u2013332","journal-title":"Medicine (Baltimore)"},{"key":"8517_CR13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/B978-0-7020-4086-3.00032-1","volume":"119","author":"AJ Kooi van der","year":"2014","unstructured":"van der Kooi AJ, de Visser M (2014) Idiopathic inflammatory myopathies. Handb Clin Neurol 119:495\u2013512","journal-title":"Handb Clin Neurol"},{"key":"8517_CR14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.23302","volume":"45","author":"DE Furst","year":"2012","unstructured":"Furst DE, Amato AA, Iorga SR, Gajria K, Fernandes AW (2012) Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve 45:676\u2013683","journal-title":"Muscle Nerve"},{"key":"8517_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.12194","volume":"175","author":"PO Carstens","year":"2013","unstructured":"Carstens PO (2013) Diagnosis, pathogenesis and treatment of myositis: recent advances. Clin Exp Immunol 175:349\u2013358","journal-title":"Clin Exp Immunol"},{"key":"8517_CR16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer A, Meyer N, Schaeffer N, Gottenberg JE, Geny B, Sibilia J (2015) Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 54:50\u201363","journal-title":"Rheumatology"},{"key":"8517_CR17","unstructured":"Medsger TA, Oddis CV (1997) Inflammatory muscle disease. Clinical features. In J.H. Klippel, P.A. Dieppe (ed) Rheumatology. Mosby 2nd edition volume 2. pp. 7.13.1-13"},{"key":"8517_CR18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.2009.04190.x","volume":"1","author":"EC Ebert","year":"2010","unstructured":"Ebert EC (2010) Review article: the gastrointestinal complications of myositis. Aliment Pharmacol Ther 1:359\u201365","journal-title":"Aliment Pharmacol Ther"},{"key":"8517_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2214\/ajr.142.2.397","volume":"142","author":"CE Blane","year":"1984","unstructured":"Blane CE, White SJ, Braunstein EM, Bowyer SL, Sullivan DB (1984) Patterns of calcification in childhood dermatomyositis. Am J Roentgenol 142:397\u2013400","journal-title":"Am J Roentgenol"},{"key":"8517_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","volume":"148","author":"SJ Balin","year":"2012","unstructured":"Balin SJ, Wetter DA, Andersen LK, Davis MD (2012) Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996\u20132009. Arch Dermatol 148:455\u2013462","journal-title":"Arch Dermatol"},{"key":"8517_CR21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/ket360","volume":"53","author":"M Shimizu","year":"2014","unstructured":"Shimizu M, Ueno K, Ishikawa S et al (2014) Role of activated macrophage and inflammatory cytokines in the development of calcinosis in juvenile dermatomyositis. Rheumatology (Oxford) 53:766\u2013767","journal-title":"Rheumatology (Oxford)"},{"key":"8517_CR22","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/art.24039","volume":"58","author":"G Mamyrova","year":"2008","unstructured":"Mamyrova G, O\u2019Hanlon TP, Sillers L et al (2008) Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis Rheum 58:3941\u20133950","journal-title":"Arthritis Rheum"},{"key":"8517_CR23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.2005.044602","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Guerini H, Wipff J et al (2006) Radiological hand involvement in systemic sclerosis. Ann Rheum 65:1088\u20131092","journal-title":"Ann Rheum"},{"key":"8517_CR24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1006\/bbrc.2000.3747","volume":"27","author":"A Farzaneh-Far","year":"2000","unstructured":"Farzaneh-Far A, Proudfoot D, Weissberg PL et al (2000) Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem Biophys Res Commun 27:736\u2013740","journal-title":"Biochem Biophys Res Commun"},{"key":"8517_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/rheumatology\/kem360","volume":"47","author":"MJH Summerer van","year":"2008","unstructured":"van Summerer MJH, Spliet WGM, Royen-Kerkhof A et al (2008) Calcinosis in juvenile dermatomyositis: a possible role for the vitamin K-dependent protein matrix gla protein. Rheumatology 47:267\u2013271","journal-title":"Rheumatology"},{"key":"8517_CR26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archderm.140.3.365","volume":"140","author":"S Weinel","year":"2004","unstructured":"Weinel S, Callen JP (2004) Calcinosis cutis complicating adult-onset dermatomyositis. Arch Dermatol 140:365\u2013366","journal-title":"Arch Dermatol"},{"key":"8517_CR27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","volume":"103","author":"SL Bowyer","year":"1983","unstructured":"Bowyer SL, Blane CE, Sullivan DB, Cassidy JT (1983) Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcifi cation. J Pediatrics 103:882\u2013888","journal-title":"J Pediatrics"},{"key":"8517_CR28","first-page":"1198","volume":"25","author":"LM Pachman","year":"1998","unstructured":"Pachman LM, Hayford JR, Chung A et al (1998) Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheum 25:1198\u20131204","journal-title":"J Rheum"},{"key":"8517_CR29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1590\/S0021-75572008000100012","volume":"84","author":"AM Sallum","year":"2008","unstructured":"Sallum AM, Pivato FC, Doia-Filho U et al (2008) Risk factors associated with calcinosis of juvenile dermatomyositis. J Pediatr (Rio J) 84:68\u201374","journal-title":"J Pediatr (Rio J)"},{"key":"8517_CR30","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Wedderburn LR, Chinoy H et al (2009) Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 60:1807\u20131814","journal-title":"Arthritis Rheum"},{"key":"8517_CR31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","volume":"150","author":"A Valenzuela","year":"2014","unstructured":"Valenzuela A, Chung L, Casciola-Rosen L et al (2014) Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol 150:724\u2013729","journal-title":"JAMA Dermatol"},{"key":"8517_CR32","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","volume":"14","author":"A Ceribelli","year":"2012","unstructured":"Ceribelli A, Fredi M, Taraborelli M et al (2012) Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis. Arthritis Res Ther 14:R97","journal-title":"Arthritis Res Ther"},{"key":"8517_CR33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","volume":"12","author":"B Hervier","year":"2012","unstructured":"Hervier B, Devilliers H, Stanciu R et al (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmunity Rev 12:210\u2013217","journal-title":"Autoimmunity Rev"},{"key":"8517_CR34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1183\/16000617.00002015","volume":"24","author":"JC Lega","year":"2015","unstructured":"Lega JC, Reynaud Q, Belot A, Fabien N, Durieu I, Cottin V (2015) Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 24:216\u2013238","journal-title":"Eur Respir Rev"},{"key":"8517_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1183\/09031936.03.00026703","volume":"22","author":"V Cottin","year":"2003","unstructured":"Cottin V, Thivolet-B\u00e9jui F, Reynaud-Gaubert M et al (2003) Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 22:245\u2013250","journal-title":"Eur Respir J"},{"key":"8517_CR36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2249.2002.01933.x","volume":"129","author":"K Kurasawa","year":"2002","unstructured":"Kurasawa K, Nawata Y, Takabayashi K et al (2002) Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis\/polymyositis. Clin Exp Immunol 129:541\u2013548","journal-title":"Clin Exp Immunol"},{"key":"8517_CR37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.23571","volume":"59","author":"M Fathi","year":"2008","unstructured":"Fathi M, Vikgren J, Boijsen M et al (2008) Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 59:677\u2013685","journal-title":"Arthritis Rheum"},{"key":"8517_CR38","first-page":"260","volume":"35","author":"S Hayashi","year":"2008","unstructured":"Hayashi S, Tanaka M, Kobayashi H et al (2008) High-resolution computed tomography characterization of interstitial lung diseases in polymyositis\/dermatomyositis. J Rheumatol 35:260\u2013269","journal-title":"J Rheumatol"},{"key":"8517_CR39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005382-199203000-00006","volume":"7","author":"MI Schwarz","year":"1992","unstructured":"Schwarz MI (1992) Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging 7:46\u201354","journal-title":"J Thorac Imaging"},{"key":"8517_CR40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0049-0172(86)90014-4","volume":"15","author":"MC Hochberg","year":"1986","unstructured":"Hochberg MC, Feldman D, Stevens MB (1986) Adult onset polymyositis\/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Sem Arthritis Rheum 15:168\u2013178","journal-title":"Sem Arthritis Rheum"},{"key":"8517_CR41","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0002-9149(78)90871-8","volume":"41","author":"JS Gottdiener","year":"1978","unstructured":"Gottdiener JS, Sherber HS, Hawley RJ, Engel WK (1978) Cardiac manifestations in polymyositis. Am J Cardiol 41:1141\u20131149","journal-title":"Am J Cardiol"},{"key":"8517_CR42","first-page":"373","volume":"14","author":"L Gonzales Lopez","year":"1996","unstructured":"Gonzales Lopez L, Gamez-Nava JI, Sanchez L et al (1996) Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 14:373\u2013379","journal-title":"Clin Exp Rheumatol"},{"key":"8517_CR43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780221007","volume":"22","author":"CE Denbow","year":"1979","unstructured":"Denbow CE, Lie T, Trancredi RG, Bunch TW (1979) Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 22:1088\u20131092","journal-title":"Arthritis Rheum"},{"key":"8517_CR44","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.CIR.0000118493.13323.81","volume":"109","author":"H Mahrholdt","year":"2004","unstructured":"Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109:1250\u20131258","journal-title":"Circulation"},{"key":"8517_CR45","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/clc.4960161110","volume":"16","author":"AJ Taylor","year":"1993","unstructured":"Taylor AJ, Wortham DC, Burge JR, Rogan KM (1993) The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol 16:802\u2013808","journal-title":"Clin Cardiol"},{"key":"8517_CR46","first-page":"1779","volume-title":"Heart disease. A textbook of cardiovascular medicine","author":"JS Coblyn","year":"1997","unstructured":"Coblyn JS, Weinblatt ME (1997) Rheumatic diseases and the heart. In: Braunwald E (ed) Heart disease. A textbook of cardiovascular medicine. WB Saunders & Co, Philadelphia, pp 1779\u201380"},{"issue":"38","key":"8517_CR47","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/rheumatology\/38.11.1153","volume":"1999","author":"G Riemekasten","year":"1999","unstructured":"Riemekasten G, Opitz C, Audring H et al (1999) Beware of the heart, the multiple picture of cardiac involvement in myositis. Rheumatol 1999(38):1153\u20131157","journal-title":"Rheumatol"},{"key":"8517_CR48","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.1984.04400020097015","volume":"144","author":"R Stern","year":"1984","unstructured":"Stern R, Godbold JH, Chess Q, Kagen LJ (1984) ECG abnormalities in polymyositis. Arch Intern Med 144:2185\u20132189","journal-title":"Arch Intern Med"},{"key":"8517_CR49","first-page":"809","volume":"22","author":"JT Lie","year":"1995","unstructured":"Lie JT (1995) Cardiac manifestations in polymyositis\/dermatomyositis: how to get to the heart of the matter. J Rheumatol 22:809\u2013811","journal-title":"J Rheumatol"},{"key":"8517_CR50","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0735-1097(98)00397-0","volume":"32","author":"U Kuhl","year":"1998","unstructured":"Kuhl U, Lauer B, Souvatzoglu M, Vosberg H, Schultheiss HP (1998) Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis: evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis. J Am Coll Cardiol 32:1371\u20131376","journal-title":"J Am Coll Cardiol"},{"key":"8517_CR51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410190203","volume":"19","author":"K Arahata","year":"1986","unstructured":"Arahata K, Engel AG (1986) Monoclonal antibody analysis of mononuclear cells in myopathies III: immunoelectron microscopy aspects of cell-mediated muscle fibre injury. Ann Neurol 19:112\u2013125","journal-title":"Ann Neurol"},{"key":"8517_CR52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-857X(02)00030-3","volume":"28","author":"MC Dalakas","year":"2002","unstructured":"Dalakas MC (2002) Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin N Am 28:779\u2013798","journal-title":"Rheum Dis Clin N Am"},{"key":"8517_CR53","first-page":"66","volume":"28","author":"FL Mastaglia","year":"2009","unstructured":"Mastaglia FL (2009) Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of MHC. Acta Myol 28:66\u201371","journal-title":"Acta Myol"},{"key":"8517_CR54","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jocn.2008.01.011","volume":"15","author":"M Needham","year":"2008","unstructured":"Needham M, Corbett A, Day T et al (2008) Prevalence of sporadic inclusion body myositis and factors contributing of delayed diagnosis. J Clin Neurosci 15:1350\u20131353","journal-title":"J Clin Neurosci"},{"key":"8517_CR55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocn.2014.09.012","volume":"22","author":"FL Mastaglia","year":"2015","unstructured":"Mastaglia FL, Needham M (2015) Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. J Clin Neurosci 22:6\u201313","journal-title":"J Clin Neurosci"},{"key":"8517_CR56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/mus.20958","volume":"37","author":"CE Jackson","year":"2008","unstructured":"Jackson CE, Barohn RJ, Gronseth G et al (2008) Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve 37:473\u2013476","journal-title":"Muscle Nerve"},{"key":"8517_CR57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mus.23292","volume":"46","author":"K Hokkoku","year":"2012","unstructured":"Hokkoku K, Sonoo M, Higashihara M, St\u00e5lberg E, Shimizu T (2012) Electromyographs of the flexor digitorum profundus muscle are useful for the diagnosis of inclusion body myositis. Muscle Nerve 46:181\u2013186","journal-title":"Muscle Nerve"},{"key":"8517_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24661","author":"G Tasca","year":"2015","unstructured":"Tasca G, Monforte M, De Fino C, Kley RA, Ricci E, Mirabella M (2015) MRI pattern recognition in sporadic inclusion body myositis. Muscle Nerve. doi: 10.1002\/mus.24661 , Mar 25","journal-title":"Muscle Nerve"},{"key":"8517_CR59","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJ Hengstman","year":"2006","unstructured":"Hengstman GJ, ter Laak HJ, Vree Egberts WT et al (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65:1635\u20131238","journal-title":"Ann Rheum Dis"},{"key":"8517_CR60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Casciola-Rosen LA (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase (HMGCR) in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63:713\u2013721","journal-title":"Arthritis Rheum"},{"key":"8517_CR61","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.50.3.764","volume":"50","author":"MI Levin","year":"1998","unstructured":"Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A (1998) Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 50:764\u2013767","journal-title":"Neurology"},{"key":"8517_CR62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mus.20693","volume":"35","author":"D Dimitri","year":"2007","unstructured":"Dimitri D, Andre C, Roucoules J, Hosseini H, Humbel RL, Authier FJ (2007) Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology. Muscle Nerve 35:389\u2013395","journal-title":"Muscle Nerve"},{"key":"8517_CR63","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0190-9622(91)70153-S","volume":"24","author":"RL Euwer","year":"1991","unstructured":"Euwer RL, Sontheimer RD (1991) Amyopathic dermatomyositis (dermatomyositis sine myositis) presentation of six new cases and review of the literature. J Am Acad Dermatol 24:959\u2013966","journal-title":"J Am Acad Dermatol"},{"key":"8517_CR64","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626\u2013436","journal-title":"J Am Acad Dermatol"},{"key":"8517_CR65","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archdermatol.2010.134","volume":"146","author":"PA Morganroth","year":"2010","unstructured":"Morganroth PA, Kreider ME, Okawa J, Taylor L, Werth VP (2010) Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. Arch Dermatol 146:729\u2013738","journal-title":"Arch Dermatol"},{"key":"8517_CR66","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10067-009-1152-9","volume":"28","author":"H Cao","year":"2009","unstructured":"Cao H, Parikh TN, Zheng J (2009) Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol 28:979\u2013984","journal-title":"Clin Rheumatol"},{"key":"8517_CR67","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1378\/chest.08-2740","volume":"136","author":"H Mukae","year":"2009","unstructured":"Mukae H, Ishimoto H, Sakamoto N et al (2009) Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 136:1341\u20131347","journal-title":"Chest"},{"key":"8517_CR68","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1183\/09031936.06.00038806","volume":"28","author":"T Suda","year":"2006","unstructured":"Suda T, Fujisawa T, Enomoto N et al (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28:1005\u20131012","journal-title":"Eur Respir J"},{"key":"8517_CR69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2012.06.004","volume":"12","author":"L Iaccarino","year":"2013","unstructured":"Iaccarino L, Gatto M, Bettio S et al (2013) Overlap connective tissue disease syndromes. Autoimmunity Review 12:363\u2013373","journal-title":"Autoimmunity Review"},{"key":"8517_CR70","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3899\/jrheum.090652","volume":"37","author":"JC Lega","year":"2010","unstructured":"Lega JC, Cottin V, Fabien N, Thivolet-B\u00e9jui F, Cordier JF (2010) Interstitial lung disease associated with anti-PM\/Scl or anti-aminoacyl- tRNA synthetase autoantibodies: a similar condition? J Rheumatol 37:1000\u20131009","journal-title":"J Rheumatol"},{"key":"8517_CR71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","volume":"91","author":"A Rigolet","year":"2012","unstructured":"Rigolet A, Musset L, Dubourg O et al (2012) Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine (Baltimore) 91:95\u2013102","journal-title":"Medicine (Baltimore)"},{"key":"8517_CR72","first-page":"118","volume":"31","author":"I Cavazzana","year":"2013","unstructured":"Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F (2013) A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. Clin Exp Rheumatol 31:118\u2013121","journal-title":"Clin Exp Rheumatol"},{"key":"8517_CR73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1191\/0961203302lu186oa","volume":"11","author":"NA Dayal","year":"2002","unstructured":"Dayal NA, Isenberg DA (2002) SLE\/myositis overlap: are the manifestations of SLE different in overlap disease? Lupus 11:293\u2013298","journal-title":"Lupus"},{"key":"8517_CR74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","volume":"77","author":"A Vancsa","year":"2010","unstructured":"Vancsa A, Gergely L, Ponyi A et al (2010) Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine 77:125\u2013130","journal-title":"Joint Bone Spine"},{"key":"8517_CR75","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1097\/MD.0000000000001144","volume":"94","author":"L Cavagna","year":"2015","unstructured":"Cavagna L, Nu\u00f1o L, Scir\u00e8 CA, AENEAS (American, European NEtwork of Antisynthetase Syndrome) collaborative group et al (2015) Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study. Medicine (Baltimore) 94:e1144","journal-title":"Medicine (Baltimore)"},{"key":"8517_CR76","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","volume":"33","author":"LA Aguila","year":"2014","unstructured":"Aguila LA, Ugolini Lopes MR, Zon Pretti F et al (2014) Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis. Clin Rheumatol 33:1093\u20131098","journal-title":"Clin Rheumatol"},{"key":"8517_CR77","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/RHU.0000000000000038","volume":"20","author":"T Mathur","year":"2014","unstructured":"Mathur T, Manadan AM, Thiagarajan S, Hota B, Block JA (2014) Serum transaminases are frequently elevated at time of diagnosis of idiopatic inflammatory myopathy and normalize with creatine kinase. J Clin Rheumatol 20:130\u2013132","journal-title":"J Clin Rheumatol"},{"key":"8517_CR78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/10408368409165773","volume":"20","author":"JA Lott","year":"1984","unstructured":"Lott JA, Landesman PW (1984) The enzymology of skeletal muscle disorders. Crit Rev Clin Lab Sci 20:153\u2013190","journal-title":"Crit Rev Clin Lab Sci"},{"key":"8517_CR79","first-page":"563","volume":"22","author":"M Fujimoto","year":"1995","unstructured":"Fujimoto M, Sato S, Ihn H, Kikuchi K, Yamada N, Takehara K (1995) Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis. J Rheumatol 22:563\u2013565","journal-title":"J Rheumatol"},{"key":"8517_CR80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00124743-200204000-00007","volume":"8","author":"AI Quintero-Del Rio","year":"2002","unstructured":"Quintero-Del Rio AI, Punaro M, Pascual V (2002) Faces of eosinophilic fasciitis in childhood. J Clin Rheumatol 8:99\u2013103","journal-title":"J Clin Rheumatol"},{"key":"8517_CR81","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/jnnp.2008.161448","volume":"80","author":"K Nozaki","year":"2009","unstructured":"Nozaki K, Pestronk A (2009) High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology. J Neurol Neurosurg Psychiatry 80:904\u2013908","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8517_CR82","first-page":"548","volume":"30","author":"L Casciola Rosen","year":"2012","unstructured":"Casciola Rosen L, Hall JC, Mammen AL, Christopher-Stine L, Rosen A (2012) Isolated elevation of aldolase in the serum of myositis patients: a potential biomarker of damaged early regenerating muscle cells. Clin Exp Rheumatol 30:548\u2013553","journal-title":"Clin Exp Rheumatol"},{"key":"8517_CR83","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rieder","year":"2011","unstructured":"Rieder LG, Werth VP, Huber AM et al (2011) Measures for adult and juvenile dematomyositis, polymyositis, and inclusion body myositis. Arthritis Care Res 63:S118\u2013S157","journal-title":"Arthritis Care Res"},{"key":"8517_CR84","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","volume":"40","author":"FW Miller","year":"2001","unstructured":"Miller FW, Rider LG, Chung YL et al (2001) Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology 40:1262\u20131273","journal-title":"Rheumatology"},{"key":"8517_CR85","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/art.23248","volume":"59","author":"N Ruperto","year":"2008","unstructured":"Ruperto N, Ravelli A, Pistorio A et al (2008) The provisional Paediatric Rheumatology International Trials Organisation\/American College of Rheumatology\/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 59:4\u201313","journal-title":"Arthritis Rheum"},{"key":"8517_CR86","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rieder","year":"2010","unstructured":"Rieder LG, Koziol D, Giannini EH et al (2010) Validation of manual muscle testing and a subset of eight muscles (MMT8) for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res 62:465\u2013472","journal-title":"Arthritis Care Res"},{"key":"8517_CR87","first-page":"603","volume":"30","author":"LG Rieder","year":"2003","unstructured":"Rieder LG, Giannini EH, Harris-Love M et al (2003) Defining clinical improvement in adult and juvenile myositis. J Rheumatol 30:603\u2013617","journal-title":"J Rheumatol"},{"key":"8517_CR88","first-page":"447","volume":"86","author":"EM Hay","year":"1993","unstructured":"Hay EM, Bacon PA, Gordon C et al (1993) The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 86:447\u2013458","journal-title":"Q J Med"},{"key":"8517_CR89","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0032-1329201","volume":"32","author":"MM Dimachkie","year":"2012","unstructured":"Dimachkie MM, Barohn RJ (2012) Idiopathic inflammatory myopathies. Sem Neurol 32:227\u2013236","journal-title":"Sem Neurol"},{"key":"8517_CR90","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","volume":"92","author":"TW Bunch","year":"1980","unstructured":"Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG (1980) Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med 92:365\u2013369","journal-title":"Ann Intern Med"},{"key":"8517_CR91","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993\u20132000","journal-title":"N Engl J Med"},{"key":"8517_CR92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"J Vencovsk\u00fd","year":"2000","unstructured":"Vencovsk\u00fd J, Jarosov\u00e1 K, Mach\u00e1cek S et al (2000) Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29:95\u2013102","journal-title":"Scand J Rheumatol"},{"key":"8517_CR93","first-page":"S53","volume":"199","author":"J Miller","year":"2002","unstructured":"Miller J, Walsh Y, Saminaden S, Lecky BRF, Winer JB (2002) Randomised double blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy. J Neurol Sci 199:S53","journal-title":"J Neurol Sci"},{"key":"8517_CR94","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","volume":"41","author":"L Villalba","year":"1998","unstructured":"Villalba L, Hicks JE, Adams EM et al (1998) Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum 41:392\u2013399","journal-title":"Arthritis Rheum"},{"key":"8517_CR95","unstructured":"WITHDRAWN: immunosuppresant and immunomodulatory treatment dor dermatomysitis and polymyositis (2009) Cochrane database Syst Rev 7: CD003643. Doi: 10.1002\/14561858"},{"key":"8517_CR96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ard.61.1.37","volume":"61","author":"MG Danieli","year":"2002","unstructured":"Danieli MG, Malcangi G, Palmieri C et al (2002) Cyclosporin A and intravenous immunoglobulin treatment in polymyositis\/dermatomyositis. Ann Rheum Dis 61:37\u201342","journal-title":"Ann Rheum Dis"},{"key":"8517_CR97","doi-asserted-by":"publisher","unstructured":"Rose MR, Jones K, Leong K et al (2015) Treatment for inclusion body myositis. Cochrane Database Syst Rev 30;6: CD001555. doi: 10.1002\/14651858.CD001555","DOI":"10.1002\/14651858.CD001555"},{"key":"8517_CR98","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/BOR.0b013e32834f19f5","volume":"24","author":"H Alexanderson","year":"2012","unstructured":"Alexanderson H, Lundberg IE (2012) Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies. Curr Opin Rheumatol 24:201\u2013207","journal-title":"Curr Opin Rheumatol"},{"key":"8517_CR99","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/BOR.0000000000000109","volume":"26","author":"IE Lundberg","year":"2014","unstructured":"Lundberg IE, Vencovsky J, Alexandreson H (2014) Therapy of myositis: biological and physical. Curr Opin Rheumatol 26:704\u2013711","journal-title":"Curr Opin Rheumatol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8517-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8517-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8517-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8517-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:49:01Z","timestamp":1559425741000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8517-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["8517"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8517-4","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]}}}